An economic analysis conducted to simulate clinical cost and quality adjusted life years (QALY) with the AutoloGel System versus Alternative Technologies found that 5 year direct wound care costs for diabetic foot ulcer were substantially lower in AutoloGel treated patients12.
Read the full article published December 2008 in Advances in Skin & Wound Care - An Evidence-Based Model Comparing the Cost-effectiveness of Platelet-Rich Plasma Gel to Alternative Therapies for Patients with Nonhealing Diabetic Foot Ulcers
12 Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care 2008; 21(12):568-75